Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials

Backhed, 2005, Host bacterial mutualism in the human intestine, Science, 307, 1915, 10.1126/science.1104816

Hooper, 2002, How host-microbial interactions shape the nutrient environment of the mammalian intestine, Annu. Rev. Nutr., 22, 283, 10.1146/annurev.nutr.22.011602.092259

Chueca, 2015, Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains, Nutrients, 7, 3999, 10.3390/nu7063999

McCoy, 2015, New developments providing mechanistic insight into the impact of the microbiota on allergic disease, Clin. Immunol., 159, 170, 10.1016/j.clim.2015.05.007

Bass, 2015, Severe childhood obesity: An under-recognised and growing health problem, Postgrad. Med. J., 91, 639, 10.1136/postgradmedj-2014-133033

Lanthier, 2014, Adipose tissues as endocrine target organs, Best Pract. Res. Clin. Gastroenterol., 28, 545, 10.1016/j.bpg.2014.07.002

Qin, 2012, A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature, 490, 55, 10.1038/nature11450

Forslund, 2015, Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota, Nature, 7581, 262, 10.1038/nature15766

Qin, 2010, A human gut microbial gene catalogue established by metagenomic sequencing, Nature, 464, 59, 10.1038/nature08821

Karlsson, 2013, Gut metagenome in European women with normal, impaired and diabetic glucose control, Nature, 498, 99, 10.1038/nature12198

Turnbaugh, 2009, A core gut microbiome in obese and lean twins, Nature, 457, 480, 10.1038/nature07540

Sanchez, 2014, Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women, Br. J. Nutr., 111, 1507, 10.1017/S0007114513003875

Hong, 2014, Roles of physical activity and cardiorespiratory fitness on sex difference in insulin resistance in late elementary years, J. Exerc. Nutr. Biochem., 18, 361, 10.5717/jenb.2014.18.4.361

Morange, 2002, The insulin resistance syndrome: Implications for thrombosis and cardiovascular disease, Pathophysiol. Haemost. Thromb., 32, 269, 10.1159/000073579

2014, Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective, World J. Gastroenterol., 20, 17737, 10.3748/wjg.v20.i47.17737

Larsen, N., Vogensen, F.K., van den Berg, F.W.J., Nielsen, D.S., Andreasen, A.S., Pedersen, B.K., Al-Soud, W.A., Sørensen, S.J., Hansen, L.H., and Jakobsen, M. (2010). Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE, 5.

Hulston, 2015, Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects, Br. J. Nutr., 113, 596, 10.1017/S0007114514004097

Ley, 2005, Obesity alters gut microbial ecology, Proc. Natl. Acad. Sci. USA, 102, 11070, 10.1073/pnas.0504978102

World Health Organization and Food & Agriculture Organization (2002). Guidelines for the Evaluation of Probiotics in Food, FAO/WHO. Available online: ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.

Plaza-Diaz, J., Gomez-Llorente, C., Abadia-Molina, F., Saez-Lara, M.J., Campaña-Martin, L., Muñoz-Quezada, S., Romero, F., Gil, A., and Fontana, L. (2014). Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats. PLoS ONE, 9.

World Health Organization, Food and Agricultural Organization of the United Nations (2001). Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria, FAO. FAO Nutrition Paper.

Hill, 2014, Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic, Nat. Rev. Gastroenterol. Hepatol., 11, 506, 10.1038/nrgastro.2014.66

Kruis, 2004, Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine, Gut, 53, 1617, 10.1136/gut.2003.037747

Gil, 2012, Probiotic mechanisms of action, Ann. Nutr. Metab., 61, 160, 10.1159/000342079

Fontana, 2013, Sources, isolation, characterisation and evaluation of probiotics, Br. J. Nutr., 2, S35, 10.1017/S0007114512004011

Pineiro, 2008, FAO Technical meeting on prebiotics, J. Clin. Gastroenterol., 42, S156, 10.1097/MCG.0b013e31817f184e

Upadhyay, 2012, Probiotics: A Review, J. Clin. Outcomes Manag., 19, 76

Kim, 2013, Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing, DNA Res., 20, 241, 10.1093/dnares/dst006

Ferrario, 2014, Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults, J. Nutr., 144, 1787, 10.3945/jn.114.197723

Yoo, 2016, Probiotics and prebiotics: Present status and future perspectives on metabolic disorders, Nutrients, 8, 173, 10.3390/nu8030173

Larsen, 2013, Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents, Clin. Nutr., 32, 935, 10.1016/j.clnu.2013.02.007

Larsen, 2012, Probiotics to adolescents with obesity: Effects on Inflammation and metabolic syndrome, J. Pediatr. Gastroenterol. Nutr., 55, 673, 10.1097/MPG.0b013e318263066c

Kadooka, 2010, Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial, Eur. J. Clin. Nutr., 64, 636, 10.1038/ejcn.2010.19

Kadooka, 2013, Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial, Br. J. Nutr., 110, 1696, 10.1017/S0007114513001037

Sharafedtinov, 2013, Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients—A randomized double-blind placebo-controlled pilot study, Nutr. J., 12, 138, 10.1186/1475-2891-12-138

Zarrati, 2014, Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet, J. Am. Coll. Nutr., 33, 417, 10.1080/07315724.2013.874937

Zarrati, 2013, Lactobacillus acidophilus La5, Bifidobacterium BB12, and Lactobacillus casei DN001 modulate gene expression of subset specific transcription factors and cytokines in peripheral blood mononuclear cells of obese and overweight people, Biofactors, 39, 633, 10.1002/biof.1128

Zarrati, 2013, Relationship between probiotic consumption and IL-10 and IL-17 secreted by PBMCs in overweight and obese people, Iran. J. Allergy Asthma Immunol., 12, 404

Raben, 2000, Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases, Eur. J. Clin. Nutr., 54, 288, 10.1038/sj.ejcn.1600937

Rajkumar, 2014, Effect of probiotic (VSL#3) and Ω-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: A randomized, controlled trial, Mediat. Inflamm., 2014, 348959, 10.1155/2014/348959

Brahe, 2015, Dietary modulation of the gut microbiota—A randomised controlled trial in obese postmenopausal women, Br. J. Nutr., 114, 406, 10.1017/S0007114515001786

Ivey, 2014, The effects of probiotic bacteria on glycaemic control in overweight men and women: A randomised controlled trial, Eur. J. Clin. Nutr., 68, 447, 10.1038/ejcn.2013.294

Ivey, 2015, The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial, Nutr. Metab. Cardiovasc. Dis., 25, 46, 10.1016/j.numecd.2014.07.012

Safavi, 2013, The effects of synbiotic supplementation on some cardio metabolic risk factors in overweight and obese children: A randomized triple-masked controlled trial, Int. J. Food Sci. Nutr., 64, 687, 10.3109/09637486.2013.775224

Ipar, 2015, Effects of synbiotic on anthropometry, lipid profile and oxidative stress in obese children, Benef. Microbes, 6, 775, 10.3920/BM2015.0011

Leber, 2012, The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: An open label, randomized pilot study, Eur. J. Clin. Nutr., 66, 1110, 10.1038/ejcn.2012.103

Tripolt, 2013, Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, β-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome—A pilot study, J. Dairy Sci., 96, 89, 10.3168/jds.2012-5863

Barreto, 2014, Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome, Nutrition, 30, 939, 10.1016/j.nut.2013.12.004

Eslamparast, 2014, Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: A randomised, double-blind, placebo-controlled pilot study, Br. J. Nutr., 112, 438, 10.1017/S0007114514000919

Hariri, 2015, A randomized, double-blind, placebo-controlled, clinical trial on probiotic soy milk and soy milk: Effects on epigenetics and oxidative stress in patients with type II diabetes, Genes Nutr., 10, 52, 10.1007/s12263-015-0503-1

Tonucci, L.B., Olbrich Dos Santos, K.M., Licursi de Oliveira, L., Rocha Ribeiro, S.M., and Duarte Martino, H.S. (2015). Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clin. Nutr.

Mohamadshahi, 2014, Effects of probiotic yogurt consumption on lipid profile in type 2 diabetic patients: A randomized controlled clinical trial, J. Res. Med. Sci., 19, 531

Ejtahed, 2012, Probiotic yogurt improves antioxidant status in type 2 diabetic patients, Nutrition, 28, 539, 10.1016/j.nut.2011.08.013

Ejtahed, 2011, Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus, J. Dairy Sci., 94, 3288, 10.3168/jds.2010-4128

Andreasen, 2010, Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects, Br. J. Nutr., 104, 1831, 10.1017/S0007114510002874

Asemi, 2013, Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes, Ann. Nutr. Metab., 63, 1, 10.1159/000349922

Bahmani, 2014, Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity C-reactive protein among diabetic patients: A double-blind, randomized, controlled clinical trial, Ann. Nutr. Metab., 65, 34, 10.1159/000365153

Shakeri, 2014, Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes, Lipids, 49, 695, 10.1007/s11745-014-3901-z

Moroti, 2012, Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus, Lipids Health Dis., 11, 29, 10.1186/1476-511X-11-29

Aller, 2011, Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: A double blind randomized clinical trial, Eur. Rev. Med. Pharmacol. Sci., 15, 1090

Vajro, 2011, Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease, J. Gastroenterol. Nutr., 52, 740, 10.1097/MPG.0b013e31821f9b85

Nabavi, 2014, Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease, J. Dairy Sci., 97, 7386, 10.3168/jds.2014-8500

Alisi, 2014, Randomised clinical trial: The beneficial effects of VLS≠3 in obese children with non-alcoholic steatohepatitis, Aliment. Pharmacol. Ther., 39, 1276, 10.1111/apt.12758

Sandoval, 2015, Physiology of proglucagon petides: Role of glucagon and GLP-1 in health and disease, Physiol. Rev., 95, 513, 10.1152/physrev.00013.2014

Eslamparast, 2014, Synbiotic supplementation in nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled pilot study, Am. J. Clin. Nutr., 99, 535, 10.3945/ajcn.113.068890

Lirussi, 2007, Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis, Cochrane Database Syst. Rev., 1, CD005165

Wong, 2013, Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study, Ann. Hepatol., 12, 256, 10.1016/S1665-2681(19)31364-X